James Findley, PhD, clinical director of the Behavioral Sleep Medicine Program, is featured in a segment on cognitive behavioral therapy for insomnia. “A lot of our job is to make it absolutely crystal clear to the brain, now is the time to be awake (and) now is the time to be asleep,” Findley said.

Michael Perlis, PhD, is interviewed by WHYY about the role placebo pills may serve in treating patients with insomnia:

From WHYY: "What if you could take half as much of a drug, but still get the full benefit? WHYY's Jessica McDonald reports on early findings at the University of Pennsylvania with sleeping pills that suggests placebos have the potential to dramatically lower dosages." Listen to the full NPR story HERE.

Recent findings on the increased prevalence of completed suicide at night, between 2 and 3am, were presented at the Annual APSS Conference, 2014, by Dr. Michael Perlis. The research team also includes: Drs. Grandner, Gehrman, Dinges, Chakravorty, Basner, Brown, Ross, and Thase. Listen to Dr. Perlis' interview on NPR HERE.

TIME reports on a new study from Penn Medicine researchers, led by Michael Grandner, PhD and Jilesh Chheda, research assistant, that found history of marijuana usage, even among quitters, may disrupt a good night's rest. PsychCenteral.com, WebMD, Philadelphia Magazine, Medscape and the UK Daily Mail also reported on the research.

People who suffer from sleep disturbances are at major risk for obesity, diabetes, and coronary artery disease, according to new research from the Perelman School of Medicine at the University of Pennsylvania, led by Michael A. Grandner, PhD and Philip Gehrman, PhD, CBSM.

Michael Perlis, PhD, associate professor of Psychiatry and director of the Behavioral Sleep Medicine Program, and James Findley, PhD, DABSM, CBSM, senior staff psychologist with the Behavioral Sleep Medicine Program, were featured experts in anABC World News Tonight report on the treatment of insomnia.